115 results on '"T cells -- Health aspects"'
Search Results
2. OLD CHEMO DRUG, NEW PANCREATIC CANCER THERAPY?
3. LEANING INTO THE IMMUNE SYSTEM'S COMPLEXITY
4. HIV TRIGGERS BODY'S OWN INFLAMMATORY PATHWAYS TO KILL T CELLS
5. RESEARCHERS RECEIVE $10.2 MILLION FROM CIRM TO ADVANCE CAR T-CELL THERAPY FOR AGGRESSIVE CANCERS
6. IMMUNE CELLS BECOME EXHAUSTED WITHIN HOURS OF ENCOUNTERING TUMORS
7. MICE WITHOUT IMMUNE CELLS SHOW NO SARS-COV-2 SYMPTOMS
8. SCIENTISTS ENGINEER POTENT IMMUNE CELLS FOR 'OFF-THE-SHELF' CANCER IMMUNOTHERAPY
9. RESEARCHERS AT UMASS AMHERST SHOW HOW A SMALL STRAND OF RNA IS KEY TO FIGHTING CANCER
10. $3.4M GRANT TO TACKLE 'BIGGEST CHALLENGE' TO HIV CURE
11. CAR T-CELL THERAPY CHANGES DYNAMIC IN FIGHT AGAINST SOME CANCERS
12. T-CELL VACCINE FOR COVID-19 MAY LAST LONGER THAN CURRENT VACCINES
13. SARS-COV-2 INFECTION WEAKENS IMMUNE-CELL RESPONSE TO VACCINATION NIH-FUNDED STUDY SUGGESTS NEED TO BOOST CD8+ T CELL RESPONSE AFTER INFECTION
14. RESEARCHERS IDENTIFY KEY SOURCE OF T CELL 'EXHAUSTION'
15. NEW TECHNOLOGY SHOWS PROMISE FOR SAFER CANCER THERAPY
16. WORLD-FIRST USE OF BASE-EDITED CELLS TO TREAT 'INCURABLE' LEUKAEMIA
17. PFIZER AND BIONTECH ADVANCE NEXT-GENERATION COVID-19 VACCINE STRATEGY WITH STUDY START OF CANDIDATE AIMED AT ENHANCING BREADTH OF T CELL RESPONSES AND DURATION OF PROTECTION
18. THERAPEUTIC HIV VACCINE WITH OXFORD TECHNOLOGY ACHIEVES ENCOURAGING RESULTS
19. NOVAVAX COVID-19-INFLUENZA COMBINATION VACCINE CANDIDATE INDUCED ANTIBODY AND T-CELL RESPONSES AGAINST SARS-COV-2 AND HOMOLOGOUS AND HETEROLOGOUS INFLUENZA STR
20. HOW THE THYMUS TRAINS T CELLS TO FIGHT INFECTIONS
21. COVAXIN CAN HELP IN CONTROLLING THE VIRUS LOAD OF SARS-COV-2 AND ITS VARIANTS, REDUCING DISEASE SEVERITY: STUDY
22. T CELLS PROTECT AGAINST COVID-19 IN ABSENCE OF ANTIBODY RESPONSE
23. MAYO CLINIC RESEARCHERS LOAD CAR-T CELLS WITH ONCOLYTIC VIRUS TO TREAT SOLID CANCER TUMORS
24. NEW TOOL REVEALS HOW IMMUNE CELLS FIND THEIR TARGETS
25. BLOOD TEST FIGURES IN CANCER RISK FOR PEOPLE WITH HIV
26. COVID-19 IMMUNE RESPONSE IMPROVES FOR MONTHS AFTER VACCINATION
27. SCIENTISTS REVEAL HOW SLEEPING IMMUNE CELLS 'WAKE' TO CONFRONT FAMILIAR FOES
28. IT'S WHAT'S ON THE OUTSIDE THAT COUNTS
29. MOST PEOPLE WITH PRIOR SARS-COV-2 INFECTION OR VACCINATION HAVE T CELL IMMUNE RESPONSES AGAINST OMICRON VARIANT DESPITE LOW ANTIBODY RESPONSES
30. INOVIO ANNOUNCES STRATEGY TO ADDRESS OMICRON (B.1.1.529) AND FUTURE SARS-COV-2 VARIANTS
31. A NEW CLASS OF CAR T CELLS TARGETS PREVIOUSLY UNTARGETABLE CANCER DRIVERS
32. NEW APPROACHES TO THE DEVELOPMENT AND EVALUATION OF VACCINES AGAINST HEPATITIS VIRUSES
33. STUDY PREDICTS WHO MAY BENEFIT FROM CAR-T CELL THERAPY FOR BLOOD CANCERS
34. MODERNA ANNOUNCES FIRST PARTICIPANT DOSED IN PHASE 1 STUDY OF ITS IL-2 MRNA THERAPEUTIC
35. STUDIES UNCOVER DETAILS OF 'EXHAUSTED' IMMUNE CELLS IN PATIENTS WITH CHRONIC INFECTIONS
36. SEN. MARSHALL: ADVANCING T-CELL TESTING CAN HELP PARENTS MAKE INFORMED DECISIONS ON COVID VACCINATIONS
37. LATEST DATA ON IMMUNE RESPONSE TO COVID-19 REINFORCES NEED FOR VACCINATION, SAYS OXFORD-LED STUDY
38. DEPARTMENT OF BIOTECHNOLOGY SUPPORTED FIRST CAR-T CELL THERAPY CONDUCTED AT ACTREC, TATA HOSPITAL IN MUMBAI
39. A TRAIT OF THE RARE FEW WHOSE BODIES NATURALLY CONTROL HIV: 'TRAINED' IMMUNE CELLS
40. PENN MEDICINE CANCER CELL THERAPY PIONEER CARL JUNE, MD, RECEIVES THE SANFORD LORRAINE CROSS AWARD
41. ANTIBODIES AND T CELLS PROTECT AGAINST SARS-COV-2
42. ON B AND T LYMPHOCYTES
43. NOVEL DUAL CAR T CELL IMMUNOTHERAPY HOLDS PROMISE FOR TARGETING THE HIV RESERVOIR
44. O'HALLERAN, MARSHALL, DELBENE, AND BUCSHON SECURE MEDICARE PAYMENTS FOR INNOVATIVE CANCER THERAPIES
45. MARSHALL, DELBENE, BUCSHON, AND O'HALLERAN APPLAUD CMS FOR SECURING MEDICARE PAYMENTS ON INNOVATIVE CANCER THERAPIES
46. DELBENE, MARSHALL, BUCSHON, AND O'HALLERAN APPLAUD CMS FOR SECURING MEDICARE PAYMENTS ON INNOVATIVE CANCER THERAPIES
47. PERSISTENT IMMUNE MEMORY OF COVID-19 FOUND IN RECOVERED PATIENT T CELLS
48. LOCKING DOWN SHAPE-SHIFTING SPIKE PROTEIN AIDS DEVELOPMENT OF COVID-19 VACCINE
49. NEW STUDY REVEALS OXFORD CORONAVIRUS VACCINE PRODUCES STRONG IMMUNE RESPONSE
50. OXFORD IMMUNOTEC RELEASES T-SPOT DISCOVERY SARS-COV-2 KIT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.